Psychiatry Investig Search


Psychiatry Investig > Volume 21(4); 2024 > Article
Kwon, Park, An, Jung, and Kweon: Impact of Omicron-Variant SARS-CoV-2 Infection on Depression and Anxiety: A Community-Based Study in Korea



This study seeks to evaluate the association between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the severity of depression and anxiety in the Korean community during the period dominated by the Omicron variant.


We used data from the 2022 Daejeon Mental Health Survey, involving data of 985 participants aged 19-69 years. The data collected included SARS-CoV-2 infection experience, days post-infection, and depression and anxiety symptoms evaluated using the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder Questionnaire-7, respectively. Additionally, physical health, social activity status, and sociodemographic characteristics such as gender, age, marital status, educational level, and household income were collected. The association between SARS-CoV-2 infection and depression and anxiety were examined. Further analyses explored association between days post-infection and the severity of depression and anxiety.


There was no significant correlation between SARS-CoV-2 infection and depression and anxiety in the overall population. Notably, participants under 50 years of age exhibited a transient worsening of depression and anxiety, followed by a decrease in symptoms within 40 days. Participants aged 51 years and older showed no significant change in depression and anxiety.


This study discerned transient effects of Omicron variant infection on depression and anxiety, particularly in younger individuals. A prospective study encompassing a larger sample size is imperative to investigate the influence of SARS-CoV-2 infection on depression and anxiety.


The coronavirus disease-2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected millions of individuals worldwide, leading to over six million deaths globally by February 2022 [1]. As of December 2022, approximately 90% of the global population had acquired varying degrees of immunity to SARS-CoV-2 [2]. In late 2021, Omicron, a new variant of SARS-CoV-2 was identified, and it continues to be the dominant variant worldwide. In South Korea, Omicron variant was first detected in December 2021 and has been the dominant variant since February 2022 [3].

Impact of the COVID-19 pandemic on community mental health

The COVID-19 pandemic has caused increased community-wide mental health problems, such as depression and anxiety. Studies conducted on the general UK population during the initial pandemic stages have shown a significant increase in depression and anxiety [4]. Research conducted on the general population in Korea during the early stages of the pandemic suggests a high prevalence of depression and anxiety [5,6]. A systematic review and meta-analysis identified depression (26.9%) and anxiety (21.8%) as the prominent mental health outcomes of the COVID-19 pandemic in Chinese populations [7].

Impact of SARS-CoV-2 infection on individual mental health

SARS-CoV-2 infection has affected the mental health of individuals. Studies indicate that the infection has increased depression and anxiety cases, and the COVID-19 survivors may experience increased depression and anxiety [8]. A study in Korea also showed increased levels of depression and anxiety in hospitalized patients [9].
Debates exist regarding the duration of the mental health effects of SARS-CoV-2 infection. Some studies have reported transient effects of the infection. Matalon et al. [10] reported that depression and anxiety were relieved 1 month after acute SARS-CoV-2 infection among Israeli inpatients. Chevinsky et al. [11] discovered that depression and anxiety remitted within 30 days and 90 days, respectively, among outpatients with SARS-CoV-2 infection in the US. Klaser et al. [12] noted that depression and anxiety were alleviated within 120 days among the US community-sampled individuals who tested positive for SARS-CoV-2. In Korea, Sung et al. [13] performed a retrospective review of health records for patients treated in residential centers for mild SARS-CoV, which reported post-infection increases in depression and anxiety [13].
Meanwhile, other studies suggest a persistent effect of SARS-CoV-2 infection on depression and anxiety. Huang et al. [14] reported that depression and anxiety persisted in 23% of Chinese inpatients at 6 months post-infection. Similarly, Méndez et al. [15] found long-lasting effects of SARS-CoV-2 infection on depression and anxiety among inpatients in Spain. Kim et al. [16] found sustained depression and anxiety 12 months after the infection among inpatients in Korea.
Previous studies have several knowledge gaps in various aspects. First, predominant investigations have been conducted during the prevalence of the Delta variant and associated national lockdowns owing to increased disease severity. Thus, biological and social factors might have affected mental health. Therefore, it is crucial to understand the association between SARS-CoV-2 infection and depression and anxiety when the Omicron variant, with lower severity, is predominant. Second, previous studies have mainly focused on inpatients and outpatients infected with SARS-CoV-2. There are few studies of the association between SARS-CoV-2 infection and depression and anxiety in the community. Therefore, it is essential to observe the effect of SARS-CoV-2 infection on depression and anxiety in the community. Third, most studies are limited to countries with stringent lockdowns, such as China and various European countries. There has been little research conducted on mental health in countries with less severe lockdowns and lower fatality rates, like Korea. Thus, additional research to encompass various countries, including Korea, is essential for generalizing the association between SARS-CoV-2 infection and depression and anxiety.
This study aims to investigate the association between SARS-CoV-2 infection and the severity of psychiatric symptoms, specifically depression and anxiety, during the prevalence of the Omicron variant. Thus, we used data collected from individuals in the Daejeon community in Korea.


Study subjects

Data for this study were obtained from the 2022 Daejeon Mental Health Survey (DMHS), conducted by the Daejeon Regional Mental Health Welfare Center (DRMHWC). DRMHWC is a government-funded institution established by the Ministry of Health and Welfare and the Daejeon Metropolitan Government. The center is situated in Daejeon, a metropolitan city in the central region of Korea with a population of 1.5 million. The center conducts a comprehensive mental health survey of its citizens every 4 years, publishing the results as the DMHS [17].
The DRMHWC conducted an online survey between March 21 and 29, 2022 and employed a structured questionnaire to gather information on physical and mental health as well as demographic information from 1,000 residents of Daejeon aged 19-69. Considering the context of the ongoing COVID-19 pandemic and the prevalence of the Omicron variant, information regarding SARS-CoV-2 infection was also gathered during the DMHS. The DMHS selected proportional stratified sampling options that considered gender, age, and address as stratified variables using resident registration population data provided by the Ministry of the Interior and Safety as of the end of February 2022.
The present study acquired and analyzed the publicly available raw data from the survey released by DRMHWC. Because the data was anonymized and lacked personal identification details of participants, the need for written informed consent was waived. Ethical approval was obtained from the Institutional Review Board of Chungnam National University Hospital (CNUH 2022-08-046).


SARS-CoV-2 infection

Information about SARS-CoV-2 infection experience and the days after Omicron variant infection was collected through the DRMHWC survey. In Korea, Omicron variant has been dominant since January 2022, before which the Delta variant was the dominant. Therefore, individuals who were infected after January 2022 were classified as the Omicron variant-infected group and included in this study, whereas those infected before January 2022 were excluded.

Depression and anxiety

Depression and anxiety symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder Questionnaire-7 (GAD-7), respectively. Scores on these questionnaires were used to gauge the severity of depression and anxiety.
The PHQ-9 is a validated tool that is consistent with the diagnostic criteria for major depressive disorder outlined in the Diagnostic and Statistical Manual of Mental Disorders [18]. The responses on the PHQ-9 are scored on a 4-point Likert scale, with 0 indicating “not at all,” 1 indicating “several days,” 2 indicating “more than half the days,” and 3 indicating “nearly every day.” The total score ranges from 0 to 27, with higher scores indicating more severe depression symptoms. PHQ-9 scores ≥10 have a sensitivity of 88% and specificity of 88% for major depression or clinically relevant depression [18]. The Korean version of the PHQ-9 has been standardized for use in the general elderly population by Han et al. [19] and in a primary care setting by Choi et al. [20].
The GAD-7, a self-reporting screening tool, also employs a 4-point Likert scale to assess anxiety over the past 2 weeks [21]. The responses are graded with 0 denoting “not at all,” 1 denoting “many days,” 2 denoting “more than 7 days,” and 3 denoting “almost every day.” Therefore, the sum of the 7 items ranges from 0 to 21 points.21 GAD-7 scores ≥10 have a sensitivity of 89% and specificity of 82% for the presence of GAD [21]. The Korean version of the GAD-7 was validated by Seo and Park [22].

Physical health and social activities

The participants’ physical health and social activity status were evaluated using a self-rating questionnaire. Participants’ responses were rated on a 5-point Likert scale, with 1 indicating “very good,” 2 indicating “good,” 3 indicating “fair,” 4 indicating “poor,” and 5 indicating “very poor.” A higher score on this questionnaire indicates a greater level of dissatisfaction with the participant’s physical health and social activity status.

Other sociodemographic characteristics

In this study, several sociodemographic characteristics were assessed as covariates. These included gender, age (19-50 year group and ≥51 year group), marital status (currently married group and currently not married group; divorced, separated, widowed, or never married participants were classified as “currently not married”), educational level (less than bachelor’s degree group and bachelor’s degree or higher group), and household income per month (<4,000,000 KRW group and ≥4,000,000 KRW group; approximately 3,100 USD) as covariates.

Statistical analyses

T-test or chi-square test was conducted to compare the physical health, social activities, and other sociodemographic factors between SARS-CoV-2 infected and noninfected groups. Continuous variables are presented as mean and standard deviation, whereas categorical variables are shown as number and percentage (n, %).
We examined the association between the experience of SARS-CoV-2 infection and the severity of depression (PHQ-9) or anxiety (GAD-7) using the independent t-test.
Furthermore, we conducted a hierarchical regression analysis to assess the effect of the days after Omicron variant infection on the severity of depression and anxiety. Three models were used in this analysis: the days after Omicron variant infection was entered in Model 1. Model 2 adjusted for physical health and social activity status. Model 3 adjusted for all variables stratified by the age groups.
All statistical analyses were performed using SPSS Version 28.0 for Windows (IBM Corp., Armonk, NY, USA) statistical program, and the statistical significance level was set at <0.05.


Demographic characteristics

Table 1 shows the demographic characteristics of SARS-CoV-2 infected and noninfected participants. Among the initial 1,000 participants, 985 were included in the analyses after excluding 15 individuals infected during the Delta variant dominant period. The participants comprised 478 (48.5%) men and 507 (51.5%) women, with an average age of 45.9±13.2 years. Individuals affected by SARS-CoV-2 were significantly younger (43.4 years vs. 46.3 years, p=0.010) and reported higher satisfaction levels with their physical health status (2.8 vs. 3.0, p=0.014) and social activity status (2.8 vs. 3.1, p=0.001) compared with noninfected counterparts.

Association between SARS-CoV-2 infection and depression and anxiety

SARS-CoV-2 infection was not associated with depression and anxiety in the overall population. The mean PHQ-9 scores were 5.1 and 5.3 among the infected and noninfected individuals, respectively (p=0.626). Additionally, the mean GAD-7 scores were 3.9 and 3.9 among the infected and noninfected individuals (p=0.930).

Association between depression and anxiety and days after Omicron infection

Table 2 shows the results of the association between depression and anxiety and the days after the Omicron variant infection.
For the participants <51 years of age, the severity of depression and anxiety decreased as the days passed after infection (Figure 1). This trend remained consistent even after adjusting for variables. Participants <51 years of age experienced a mild, transient worsening of depression and anxiety. After 40 days, the PHQ-9 and the GAD-7 scores dropped to <10. Thus, no individual scored above the cutoff for mild depression and anxiety after 40 days.
In the ≥51 year age group, although there were no significant differences, Models 2 and 3 showed a significant decrease in depression, along with an insignificant decreasing trend in anxiety.


This study examined the course of depression and anxiety symptoms in a community following SARS-CoV-2 infection. We found no significant association between depression and anxiety and SARS-CoV-2 infection within the overall population. However, among younger individuals, we observed a transient effect on depression and anxiety after SARS-CoV-2 infection.

Effect of the experience of SARS-CoV-2 infection on depression and anxiety

Although previous studies have shown an association between SARS-CoV-2 infection and depression and anxiety in the community [8], our study did not find a significant association. Moreover, Jung et al. [9] found that among 102 patients with SARS-CoV-2 who were discharged from hospitalization in Korea, depression (48.1%) and anxiety (49.1%) were identified. However, our study of the general population with Omicron infection is inconsistent with previous literature findings. There are several possible explanations for the lack of association. First, considering social factors, it is plausible that individuals actively engaging in positive social support and physical activities might be prone to increased risk of SARS-CoV-2 infection. However, these same activities could exert a protective effect against depression and anxiety by promoting resilience and mitigating the negative effects of SARS-CoV-2 infection [23,24]. Second, the biological factors cannot be dismissed. The Omicron variant was considered dominant in this study. As most Omicron infections are of low severity, the potential influence on depression and anxiety might have been insignificant. Third, the effects of SARS-CoV-2 infection could be short-lived, leading to only minor effects on community-wide depression and anxiety levels. The study suggests that individuals experienced temporary bouts of depression and anxiety post-SARS-CoV-2 infection. Consequently, detecting subtle variations would necessitate larger sample sizes.

Effect of SARS-CoV-2 infection on depression and anxiety over time

It is unclear how mental sequelae caused by SARS-CoV-2 infection persist. In a study focusing on hospitalized patients with SARS-CoV-2 infection in Israel, Matalon et al. [10] found that depression and anxiety decreased within a month. Studies in outpatient and community populations in the United States have also found reductions in depression and anxiety within three months [11]. In contrast, studies conducted on hospitalized patients in China, Spain, and South Korea reported that depression and anxiety persisted for >6 months [14-16]. Our results support the findings of the aforementioned studies, which reported a short-lived effect of SARS-CoV infection on depression and anxiety.
Primarily, social factors need to be considered. Most of the studies showing long-lasting effects of SARS-CoV-2 infection have been conducted in countries with stringent lockdown regulations and high fatality rates. In contrast, this study was conducted during a period of comparatively relaxed lockdowns, reduced social media influence, and low fatality rates [25]. Therefore, these social factors could have contributed to decreased psychological stress and subsequent decreases in depression and anxiety levels [26].
Furthermore, the biological factors should also be considered. Coronaviruses can cause psychopathological effects through two pathways: direct viral infection of the central nervous system or indirect effects via immune response [27]. Considering the relatively mild nature of the Omicron variant [28], there may have been a smaller biological inflammatory response, leading to a potentially reduced effect on depression and anxiety levels. This is consistent with a previous study conducted on SARS-CoV-2 infected inpatients, where patients with Omicron variant infection exhibited decreased depression and anxiety symptoms [29]. This suggests a relatively low risk of experiencing depression and anxiety due to Omicron variant infection in community samples.

Age disparities in SARS-CoV-2 impact on depression and anxiety

We found an association between Omicron variant infection and elevated depression and anxiety symptoms among younger adults, particularly within the first month post-infection. Multiple factors contribute to these distinctions. First, social factors could play a pivotal role, considering the links between depressive and anxiety symptoms and feelings of loneliness, as well as lower resilience to stress among younger adults. Therefore, younger adults might have been particularly susceptible to symptom exacerbation during periods of lockdowns and related disruptions. Similar trends were noted in previous studies involving younger adults during the COVID-19 pandemic, highlighting the interplay between feelings of loneliness, low resilience, and increased depression and anxiety [30].
Second, biological factors should also be considered. A few studies reported elevated anxiety levels among young COVID-19 survivors, although studies on age-related biological factors remains limited [31]. Additionally, the relatively smaller cohort of older adults might have limited our ability to discern changes in depression and anxiety as older adults in this study had little effect. Therefore, future studies with larger older adult participation are warranted to elucidate this aspect.
The major strength of our study lies in the use of community sample data through proportional stratified sampling. This approach reduced the sampling bias often present in many previous studies that focused on hospitalized or outpatient populations. Additionally, by minimizing the influence of socioeconomic factors, we were able to obtain results that are more generalizable.
In the current context of ongoing sporadic SARS-CoV-2 infections continuing post-pandemic, our research provides clinical and policy implications. First, our study showed a transient intensification of depression and anxiety symptoms following a mild SARS-CoV-2 infection. This implies the need for timely screening and intervention for mental health issues immediately after infection. Second, it is necessary to establish targeted intervention strategies for young adults who are actively engaged in social activities. Enhancing the accessibility of mental health services, such as online digital mental health resources, is also needed.
However, limitations exist. The cross-sectional design hinders the establishment of causal relationships between the study variables. Potential sampling bias could arise from the online survey approach, possibly limiting generalizability to less technologically savvy or lower-income populations. It is possible that individuals with more severe symptoms were not included in the study. However, during the online survey, SARS-CoV-2 severity was generally low in Korea, which may reduce the potential for significant bias. All variables in the study were self-reported, which may limit the accuracy of variables such as diagnosis or the presence of SARS-CoV-2 infection. Therefore, further studies are necessary to address the limitations and improve the quality of our findings.
In conclusion, this study indicates that depression and anxiety symptoms may temporarily worsen in younger adults following Omicron variant infection, implying a short-lived effect on this population. Further longitudinal studies are essential to investigate the factors contributing to mental health outcomes after SARS-CoV-2 infection.


Availability of Data and Material

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors have no potential conflicts of interest to disclose.

Author Contributions

Conceptualization: Kukju Kweon. Data curation: Jina Park, Eunkyoung An. Formal analysis: Youngsook Kwon, Kukju Kweon. Funding acquisition: Kukju Kweon. Investigation: Jina Park, Eunkyoung An. Methodology: Youngsook Kwon, Sukyoung Jung, Kukju Kweon. Project administration: Kukju Kweon. Resources: Kukju Kweon. Software: Youngsook Kwon, Sukyoung Jung, Kukju Kweon. Supervision: Kukju Kweon. Validation: Sukyoung Jung, Kukju Kweon. Visualization: Youngsook Kwon, Kukju Kweon. Writing— original draft: Youngsook Kwon, Kukju Kweon. Writing—review & editing: all authors.

Funding Statement

This work was supported by research fund of Chungnam National University.


The authors thank Daejeon Regional Mental Health Welfare Center for their assistance with this research.

Figure 1.
Association between depression or anxiety and days after omicron variant infection under 50 years of age. Linear regression between days after Omicron variant infection and total scores of PHQ-9 and GAD-7. GAD-7, Generalized Anxiety Disorder 7; PHQ-9, Patient Health Questionnaire 9.
Table 1.
Comparison of demographic characteristics and mental health problems between infected and non-infected individuals
All cases (N=985) Infected (N=160) Not-infected (N=825) χ2 or t p
Ages (yr) 45.9±13.2 43.4±12.9 46.3±13.4 -2.587 0.010
 19-50 572 (58.1) 108 (67.5) 464 (56.2) 6.975 0.008
 ≥51 413 (41.9) 52 (32.5) 361 (43.8)
 Man 478 (48.5) 72 (45.0) 406 (49.2) 0.952 0.329
PHQ-9 5.1±4.7 5.3±5.1 -0.488 0.626
GAD-7 3.9±4.5 3.9±4.3 -0.088 0.930
Marital status
 Currently married 579 (58.8) 98 (61.3) 481 (58.3) 0.480 0.488
Education level
 Below bachelor’s degree 244 (24.8) 44 (27.5) 200 (24.2) 0.763 0.382
Personal monthly income
 4,000,000 KRW≤ 460 (46.7) 75 (46.9) 385 (46.7) 0.002 0.961
Social activity status 2.8±0.8 3.1±0.8 -3.227 0.001
Physical health status 2.8±0.8 3.0±0.8 -2.451 0.014

Values are presented as mean±SD or number (%) unless otherwise indicated. GAD-7, Generalized Anxiety Disorder 7; PHQ-9, Patient Health Questionnaire 9-item scale; SD, standard deviation

Table 2.
Hierarchical regression to assess depression and anxiety associated with the days after omicron variant infection
Age (yr) B SEB β F p
19-50 (N=108)
  Model 1 -0.095 0.038 -0.235* 6.197 0.014
  Model 2 -0.079 0.036 -0.195* 8.045 <0.001
  Model 3 -0.080 0.037 -0.198* 5.222 <0.001
  Model 1 -0.110 0.037 -0.277** 8.779 0.004
  Model 2 -0.082 0.034 -0.206* 10.293 <0.001
  Model 3 -0.074 0.035 -0.185* 6.215 <0.001
≥51 (N=52)
  Model 1 0.000 0.055 0.001 <0.001 0.996
  Model 2 -0.016 0.050 -0.042 4.159 0.006
  Model 3 -0.015 0.048 -0.039 3.273 0.005
  Model 1 -0.038 0.051 -0.105 0.557 0.459
  Model 2 -0.045 0.049 -0.124 2.487 0.056
  Model 3 -0.040 0.048 -0.113 1.955 0.076

* p<0.05;

** p<0.01.

Model 1 was adjusted for the days after Omicron-variant infection; Model 2 was adjusted for the days after Omicron-variant infection, physical health, and social activity status; Model 3 was adjusted for the days after Omicron-variant infection, physical health, social activity status, and other sociodemographic factors. GAD-7, Generalized Anxiety Disorder 7; PHQ-9, Patient Health Questionnaire 9


1. World Health Organization. WHO COVID-19 dashboard [Internet]. Available at: Accessed May 18, 2023.

2. World Health Organization. WHO director-general's opening remarks at the media briefing - 2 December 2022 [Internet]. Available at: Accessed May 18, 2023.

3. Park AK, Kim IH, Lee CY, Kim JA, Lee H, Kim HM, et al. Rapid emergence of the omicron variant of severe acute respiratory syndrome coronavirus 2 in Korea. Ann Lab Med 2023;43:211-213.
crossref pmid pmc
4. Pierce M, Hope H, Ford T, Hatch S, Hotopf M, John A, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatry 2020;7:883-892.
crossref pmid pmc
5. Lee H, Choi D, Lee JJ. Depression, anxiety, and stress in Korean general population during the COVID-19 pandemic. Epidemiol Health 2022;44:e2022018.
crossref pmid pmc pdf
6. Kim DM, Bang YR, Kim JH, Park JH. The prevalence of depression, anxiety and associated factors among the general public during COVID-19 pandemic: a cross-sectional study in Korea. J Korean Med Sci 2021;36:e214.
crossref pmid pmc pdf
7. Bareeqa SB, Ahmed SI, Samar SS, Yasin W, Zehra S, Monese GM, et al. Prevalence of depression, anxiety and stress in china during COVID-19 pandemic: a systematic review with meta-analysis. Int J Psychiatry Med 2021;56:210-227.
crossref pmid pdf
8. Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19-a systematic review. Brain Behav Immun 2021;97:328-348.
crossref pmid pmc
9. Jung JH, Bae EY, Ko JY. Factors associated with the mental health status of isolated COVID-19 patients in Korea. Infect Dis Health 2022;27:184-190.
crossref pmid pmc
10. Matalon N, Dorman-Ilan S, Hasson-Ohayon I, Hertz-Palmor N, Shani S, Basel D, et al. Trajectories of post-traumatic stress symptoms, anxiety, and depression in hospitalized COVID-19 patients: a one-month follow-up. J Psychosom Res 2021;143:110399
crossref pmid pmc
11. Chevinsky JR, Tao G, Lavery AM, Kukielka EA, Click ES, Malec D, et al. Late conditions diagnosed 1-4 months following an initial coronavirus disease 2019 (COVID-19) encounter: a matched-cohort study using inpatient and outpatient administrative data—United States, 1 March-30 June 2020. Clin Infect Dis 2021;73(Suppl 1):S5-S16.
crossref pmid pmc pdf
12. Klaser K, Thompson EJ, Nguyen LH, Sudre CH, Antonelli M, Murray B, et al. Anxiety and depression symptoms after COVID-19 infection: results from the COVID symptom study app. J Neurol Neurosurg Psychiatry 2021;92:1254-1258.
crossref pmid pmc
13. Sung SM, Kim SH, Lee CW, Kim Y, Bae YS, Chie EK. The Association of acute signs and symptoms of COVID-19 and exacerbation of depression and anxiety in patients with clinically mild COVID-19: retrospective observational study. JMIR Public Health Surveill 2023;9:e43003.
crossref pmid pmc
14. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220-232.
pmid pmc
15. Méndez R, Balanzá-Martínez V, Luperdi SC, Estrada I, Latorre A, González-Jiménez P, et al. Long-term neuropsychiatric outcomes in COVID-19 survivors: a 1-year longitudinal study. J Intern Med 2022;291:247-251.
crossref pmid pmc pdf
16. Kim Y, Ha B, Kim SW, Chang HH, Kwon KT, Bae S, et al. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis 2022;22:93
crossref pmid pmc pdf
17. Kweon K, Park J, An E, Park J, Kwon S, Nam H, et al. A white book about 2022 Daejeon metropolitan city mental health. Daejeon: Daejeon Regional Mental Health Welfare Center; 2022.

18. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.
crossref pmid pmc
19. Han C, Jo SA, Kwak JH, Pae CU, Steffens D, Jo I, et al. Validation of the patient health questionnaire-9 Korean version in the elderly population: the Ansan geriatric study. Compr Psychiatry 2008;49:218-223.
crossref pmid
20. Choi HS, Choi JH, Park KH, Joo KJ, Ga H, Ko HJ, et al. [Standardization of the Korean version of patient health questionnaire-9 as a screening instrument for major depressive disorder]. J Korean Acad Fam Med 2007;28:114-119. Korean.

21. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-1097.
crossref pmid
22. Seo JG, Park SP. Validation of the generalized anxiety disorder-7 (GAD7) and GAD-2 in patients with migraine. J Headache Pain 2015;16:97
crossref pmid pmc pdf
23. Chen T, Lucock M. The mental health of university students during the COVID-19 pandemic: an online survey in the UK. PLoS One 2022;17:e0262562.
crossref pmid pmc
24. Sommerlad A, Marston L, Huntley J, Livingston G, Lewis G, Steptoe A, et al. Social relationships and depression during the COVID-19 lockdown: longitudinal analysis of the COVID-19 social study. Psychol Med 2022;52:3381-3390.
crossref pmid pmc
25. Ahn SH, Jang J, Park SY, Ryu BY, Lee SY, Shin EJ, et al. Outbreak report of COVID-19 during designation of class 1 infectious disease in the Republic of Korea (January 20, 2020 and April 24, 2022). Public Health Wkly Rep 2022;15:2126-2136.

26. Elmer T, Mepham K, Stadtfeld C. Students under lockdown: comparisons of students' social networks and mental health before and during the COVID-19 crisis in Switzerland. PLoS One 2020;15:e0236337
crossref pmid pmc
27. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020;87:18-22.
crossref pmid pmc
28. Arabi M, Al-Najjar Y, Mhaimeed N, Salameh MA, Paul P, AlAnni J, et al. Severity of the omicron SARS-CoV-2 variant compared with the previous lineages: a systematic review. J Cell Mol Med 2023;27:1443-1464.
pmid pmc
29. Li K, Luo K, Zhan X, Liu C, Li L, Luo X, et al. Adjusting intervention strategies for mental health of COVID-19 patients: a network analysis based on a survey in omicron-infected patients. Front Public Health 2022;10:1038296
crossref pmid pmc
30. Liu CH, Zhang E, Wong GTF, Hyun S, Hahm HC. Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: clinical implications for U.S. young adult mental health. Psychiatry Res 2020;290:113172
crossref pmid pmc
31. Brasso C, Bellino S, Blua C, Bozzatello P, Rocca P. The impact of SARS-CoV-2 infection on youth mental health: a narrative review. Biomedicines 2022;10:772
crossref pmid pmc
Facebook Twitter Linked In Google+
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 1,207 View
  • 51 Download


Browse all articles >

Editorial Office
#522, 27, Seochojungang-ro 24-gil, Seocho-gu, Seoul 06601, Korea
Tel: +82-2-717-0892    E-mail:                

Copyright © 2024 by Korean Neuropsychiatric Association.

Developed in M2PI

Close layer
prev next